Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer

Vanita Noronha, Vijay Patil, Pankaj Chaturvedi, Vijayalakshmi Mathrudev, Nandini Menon, Atanu Bhattacharjee, Ajay Singh, Zoya Peelay, Shatabdi Chakraborty, Monica Jadhav, Mitali Alone, Priyanka Bhagyavant, Manali Kolkur, Sujay Srinivas, Sudeep Das, Somnath Roy, Tanmoy Mandal, Hollis Dsouza, Saswata Saha, Rahul RaiAnne Srikanth, Darshit Shah, Arif Khan, Hemanth Muthuluri, Amit Kumar, Amit Agarwal, Anu Rajpurohit, Vasu Babu Goli, Anbarasan Sekar, Anoop Mantri, Aditya Pavan Kumar Kanteti, Swaratika Majumdar, Satvik Khaddar, Ramnath Shenoy, Prahlad Elamarthi, Narmadha Rathnasamy, Lakhan Kashyap, George Abraham, Naveen Booma, Vijay Simha, Devendra Chaukar, Prathamesh Pai, Sudhir Nair, Sarbani Laskar, Kavita Nawale, Priyanka Naidu, Sushmita Salian, Priyanka Shelar, Ravinarayan Raulo, Sachin Babanrao Dhumal, Kumar Prabhash

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science